Navigation Links
Oncolytic viruses effectively target and kill pancreatic cancer stem cells
Date:5/9/2011

Oncolytic viruses quickly infect and kill cancer stem cells, which may provide a treatment for tumors that are resistant to conventional chemotherapy and radiation, particularly pancreatic cancer, according to new research from Memorial Sloan-Kettering Cancer Center in New York. The findings are especially important since pancreatic cancer has a poor prognosis and is difficult to detect and treat at early stages.

Investigators led by Joyce Wong, MD, surgical researcher with Memorial Sloan-Kettering Cancer Center, investigated whether they could use oncolytic viruses, which are naturally occurring viruses that have been genetically engineered to be safe and express tracking genes, as a possible therapy against pancreatic cancer stem cells. These stem cells are thought to cause disease recurrence and metastasis, even after therapy, and oncolytic viruses may offer a new treatment strategy.

"What we learned is that oncolytic viruses have been engineered to selectively target cancer cells and have a low toxicity profile in animal studies," said Dr. Wong. "Targeting the cancer stem cell may enhance our ability to eradicate tumors and prevent future recurrence of disease."

While much research has been performed on isolating the cancer stem cell from various hematologic cancers, this research was based on the presence or absence of certain cell surface markers. Numerous mechanisms of how these cancer stem cells resist chemotherapy and radiation have also been examined. But to date, there have not been any studies evaluating whether genetically engineered viruses can target and kill pancreatic cancer stem cells.

Investigators sought to determine whether the viruses containing a marker gene that expresses green fluorescent protein could infect pancreatic cancer stem cells and ultimately kill the cancer stem cell. Their findings were promising and documented that viral activity was correlated with green fluorescent protein expression.

Dr. Wong added that future studies are warranted to determine whether oncolytic virus administration in vivo will help eradicate tumors and prevent future disease recurrence, and that while these initial findings are encouraging, further study is necessary to see whether oncolytic viruses will be clinically useful as a therapy.

Dr. Wong will present these data on Monday, May 9 at 10:00 a.m. CT in S505, McCormick Place.


'/>"/>

Contact: Amy Levey
alevey@gymr.com
312-791-6715
Digestive Disease Week
Source:Eurekalert

Related medicine news :

1. BUSM researchers show an oncolytic virus switches off cancer cell survival signal
2. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
3. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
4. Cold Viruses Appear Linked to Type 1 Diabetes
5. Flu Viruses Gaining Resistance, Study Confirms
6. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
7. Targeting hit-and-run cancer viruses
8. Researchers find function of proteins that can enhance the progression of viruses and cancer cells
9. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
10. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
11. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... Medical Director of its Sienna Plantation facility. , “We are pleased to announce ... said Dr. Michael (Derek) Caraway, Area Medical Director of First Choice Emergency Room – ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
(Date:8/16/2017)... ... , ... “Faith, Through The Eyes of A Child” is the creation of published author, Pauline ... down at her. Since she was in such great pain, my mother thought that her ... went well. It wasn’t until I was about eight years old, when I had a ...
(Date:8/15/2017)... California (PRWEB) , ... August 15, 2017 , ... ... definitions of disease. It’s reaching out to a patient who feels isolated. It’s ... art amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)...   Second-quarter 2017 revenues of ... share from continuing operations ... to $110 million Second-quarter ... million Second-quarter 2017 adjusted ... 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and ... driving up healthcare costs and threatening outcomes, were problems ... supply and IVD industry that support them, met this ... market researcher said that drugs of abuse, procalcitonin and ... sessions at the organization,s 69th meeting in ...
Breaking Medicine Technology: